Mid-term results show improved neurological outcomes in patients with distal arch disease, suggesting a safe alternative for repair.
The Relay™ single-branched endograft demonstrated excellent technical success and favorable neurological outcomes in patients with distal arch disease. While the limited sample size restricts inference, these findings support the use of tailored single-branched devices as a safe alternative to more complex branched configurations in anatomically suitable patients.
No takes yet. Share an insight, caveat, or question.
Stelzmueller et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: